iCell™ Cardiomyocytes are human heart cells designed to aid drug discovery and improve the predictability of drug-compound efficacy and toxicity screens, helping to weed out ineffective and potentially toxic compounds early in the pharmaceutical pipeline process before significant time and resources have been invested. iCell Cardiomyocytes are derived from induced pluripotent stem cells, spontaneously beat in vitro, and exhibit the electrophysiological and biochemical properties of normal human heart cells.